These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Carboxyterminal propeptide of type I procollagen in ELF: elevation in asbestosis, but not in pleural plaque disease. Lammi L, Ryhänen L, Lakari E, Risteli J, Pääkkö P, Ruotsalainen EM, Lähde S, Kinnula VL. Eur Respir J; 1999 Sep; 14(3):560-4. PubMed ID: 10543275 [Abstract] [Full Text] [Related]
5. Hyaluronan and procollagen type III aminoterminal peptide in serum and bronchoalveolar lavage fluid in patients with pulmonary sarcoidosis. Milman N, Kristensen MS, Bentsen K, Grode G, Frederiksen J. Sarcoidosis; 1995 Mar; 12(1):38-41. PubMed ID: 7617974 [Abstract] [Full Text] [Related]
7. Analytical, physiologic, and clinical validation of a radioimmunoassay for measurement of procollagen type III amino terminal propeptide in serum and bronchoalveolar lavage fluid obtained from dogs. Schuller S, Valentin S, Remy B, Jespers P, Foulon S, Van Israël N, Clercx C, McEntee K. Am J Vet Res; 2006 May; 67(5):749-55. PubMed ID: 16649905 [Abstract] [Full Text] [Related]
8. Procollagen types I and III aminoterminal propeptide levels during acute respiratory distress syndrome and in response to methylprednisolone treatment. Meduri GU, Tolley EA, Chinn A, Stentz F, Postlethwaite A. Am J Respir Crit Care Med; 1998 Nov; 158(5 Pt 1):1432-41. PubMed ID: 9817690 [Abstract] [Full Text] [Related]
9. Increased procollagen III aminoterminal peptide-related antigens and fibroblast growth signals in the lungs of patients with idiopathic pulmonary fibrosis. Cantin AM, Boileau R, Bégin R. Am Rev Respir Dis; 1988 Mar; 137(3):572-8. PubMed ID: 3345038 [Abstract] [Full Text] [Related]
10. Bronchoalveolar lavage fluid angiotensin-converting enzyme in interstitial lung diseases. Specks U, Martin WJ, Rohrbach MS. Am Rev Respir Dis; 1990 Jan; 141(1):117-23. PubMed ID: 2153351 [Abstract] [Full Text] [Related]
11. [Procollagen III-peptide and angiotensin converting enzyme in bronchoalveolar lavage in sarcoidosis]. Schlotfeldt D, Nowak B, Weist P. Pneumologie; 1992 Mar; 46(3):101-6. PubMed ID: 1316603 [Abstract] [Full Text] [Related]
18. Inflammatory BAL-fluid and serum parameters in HLA DR17 positive vs. DR17 negative patients with pulmonary sarcoidosis. Planck A, Eklund A, Grunewald J. Sarcoidosis Vasc Diffuse Lung Dis; 2001 Mar; 18(1):64-9. PubMed ID: 11354549 [Abstract] [Full Text] [Related]
19. Type III procollagen N-terminal propeptide, soluble interleukin-2 receptor, and von Willebrand factor in systemic sclerosis. Lee YJ, Shin KC, Kang SW, Lee EB, Kim HA, Song YW. Clin Exp Rheumatol; 2001 Mar; 19(1):69-74. PubMed ID: 11247328 [Abstract] [Full Text] [Related]
20. Twenty-four-hour osteocalcin, carboxyterminal propeptide of type I procollagen, and aminoterminal propeptide of type III procollagen rhythms in normal and growth-retarded children. Saggese G, Baroncelli GI, Bertelloni S, Cinquanta L, DiNero G. Pediatr Res; 1994 Apr; 35(4 Pt 1):409-15. PubMed ID: 8047377 [Abstract] [Full Text] [Related] Page: [Next] [New Search]